However, no statistically significant difference in survival for the Testin negative or positive lymphomas was observed within the genotype groups or between the CD3+ and B220+ lymphomas, although the numbers of mice within these comparisons were small (Supplementary Table S2). The gene discussed is PTPRC; the disease is lymphoma.